Connect to other sites within the UBM Medica Network
The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.
3 Things You (Still) Need to Know About GLP-1 Agonists
Incretin mimetic therapy for type 2 diabetes has been on the market for more than 10 years. Find out what you've learned about the GLP-1 agonists, here.
Targeting Cell Aging May Yield Diabetes Therapy
Heading the diabetes news: therapeutic targeting of cellular senescence, food order affects glucose and insulin levels, sugar causes heart muscle damage, central obesity genetic score linked to type 2 DM risk.
9 ICD-10 Tips for Endocrinologists
This slideshow presents several tips to keep in mind once ICD-10 goes live.
Elevated Triglycerides in a Woman with Type 2 Diabetes
What do current guidelines recommend as first-line treatment for patients like 51-year-old TK? Check out these options.
Hot Weather and Travel Guidelines for Your Patients
We present tips for your diabetic patients to remember while traveling and dealing with heat and humidity.
Cardiovascular Health and Type 2 Diabetes
We present 3 studies that show the importance of managing cardiovascular risks in your diabetic patients.
Diabetes Risk Linked With Hypothyroidism
Hypothyroidism increases the risk of diabetes, but in subclinical hypothyroidism the increased risk is prominent only with statin use.
Metabolic Disease Research Roundup From AACE 2015
Metabolic disorders in patients with diabetes place them at particularly high risk for CV morbidity. Find insights on Dx and Tx in these slides.
Top 10 Reasons Why Patients Come to Primary Care
What brings patients to your office—and not the specialty office down the street? Insights in this slideshow.
Abridged Diabetes Guidelines for Primary Care: 6 Noteworthy Changes
The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.
Five Top Papers From 2014 That Will Impact Your Practice
New drugs that treat stubborn illness seen often in primary care lead this group of Top 5 Papers for 2014. Type 2 diabetes, cryptogenic stroke, and hep-C are key targets.
By clicking Accept, you agree to become a member of the UBM Medica Community.